Skip to content
8-K

Material Event

BridgeBio Oncology Therapeutics, Inc. BBOT

0001193125-26-093997

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted 2025 · Dec 31, 2025 79.99M sh
Shares Diluted 2024 · Dec 31, 2024 18.3K sh
Eps Diluted 2025 · Dec 31, 2025 −$0.49
Eps Diluted 2024 · Dec 31, 2024 −$1,075.56
Eps Basic 2025 · Dec 31, 2025 −$0.49
Eps Basic 2024 · Dec 31, 2024 −$1,075.56
Sga Expense 2025 · Dec 31, 2025 $5.33M
Sga Expense 2024 · Dec 31, 2024 $2.34M
Rd Expense 2025 · Dec 31, 2025 $38.07M
Rd Expense 2024 · Dec 31, 2024 $19.54M
Net Income 2025 · Dec 31, 2025 −$38.8M
Net Income 2024 · Dec 31, 2024 −$19.69M
Operating Income 2025 · Dec 31, 2025 −$43.41M
Operating Income 2024 · Dec 31, 2024 −$21.88M